Skip to main content
Livermore
Livermore
ZHEN

Clough Capital Partners L P

SEC CIK
0001276144
Latest filing
Aug 14, 2026

The latest 13F from Clough Capital Partners L P covers Q2 2026 (filed Aug 14, 2026): 101 long positions worth $1.23B. The top 10 holdings make up 35.0% of the portfolio, and the largest is Alphabet Inc. (GOOG) at 4.2%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
40
Est. +$360.6M
Added
34
Est. +$96.5M
Reduced
20
Est. −$177.4M
Sold out
34
Est. −$153.7M

Top 5 holdings

Share of this quarter's portfolio value

  1. GOOGAlphabet Inc.
    4.2%$51.9MHistory
  2. AMZNAmazon Com Inc
    4.2%$51.7MHistory
  3. NVDANVIDIA Corp
    3.9%$47.3MHistory
  4. PHMPultegroup Inc
    3.6%$43.7MHistory
  5. DHIHorton D R Inc
    3.5%$43.1MHistory

Share of portfolio

Top 5 holdings and the other 96 positions, by share of portfolio value

  1. GOOG4.2%
  2. AMZN4.2%
  3. NVDA3.9%
  4. PHM3.6%
  5. DHI3.5%
  6. Other 96 positions80.6%

Biggest buys

New and added positions, by estimated amount bought

  1. POOLPool Corp
    +$28.0MNewHistory
  2. LLYEli Lilly & Co
    +$25.3MNewHistory
  3. WSTWest Pharmaceutical Services Inc
    +$23.8MNewHistory
  4. FERGFerguson Enterprises Inc.
    +$23.1MNewHistory
  5. KDPKeurig Dr Pepper Inc.
    +$21.9MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. POOLPool Corp
    +2.28 pp0.0% → 2.3%History
  2. LLYEli Lilly & Co
    +2.06 pp0.0% → 2.1%History
  3. WSTWest Pharmaceutical Services Inc
    +1.94 pp0.0% → 1.9%History
  4. FERGFerguson Enterprises Inc.
    +1.88 pp0.0% → 1.9%History
  5. KDPKeurig Dr Pepper Inc.
    +1.79 pp0.0% → 1.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. EXEExpand Energy Corp
    −$29.7MReducedHistory
  2. SCHWSchwab Charles Corp
    −$25.5MSold outHistory
  3. UPSUnited Parcel Service Inc
    −$23.5MSold outHistory
  4. GOOGAlphabet Inc.
    −$22.9MReducedHistory
  5. AAPLApple Inc.
    −$22.7MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. EXEExpand Energy Corp
    −3.50 pp3.6% → 0.1%History
  2. SCHWSchwab Charles Corp
    −2.46 pp2.5% → 0.0%History
  3. UPSUnited Parcel Service Inc
    −2.27 pp2.3% → 0.0%History
  4. AAPLApple Inc.
    −1.99 pp3.7% → 1.8%History
  5. ARAntero Resources Corp
    −1.76 pp2.1% → 0.3%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$1.23B
+$190.9M (+18.4%) vs. prior quarter
Positions
101
+6 vs. prior quarter
Top 10 concentration
35.0%
Top 10 as share of value
Turnover
29.3%
Q2 2026, one quarter
Average holding period
7.4 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $1.78B (Q2 2021)

Q1 2021: $1.54BQ2 2021: $1.78BQ3 2021: $1.61BQ4 2021: $1.49BQ1 2022: $1.31BQ2 2022: $773.0MQ3 2022: $669.7MQ4 2022: $986.5MQ1 2023: $927.8MQ2 2023: $993.8MQ3 2023: $931.9MQ4 2023: $904.1MQ1 2024: $909.6MQ2 2024: $915.8MQ3 2024: $977.0MQ4 2024: $873.7MQ1 2025: $792.4MQ2 2025: $997.2MQ3 2025: $1.12BQ4 2025: $1.11BQ1 2026: $1.04BQ2 2026: $1.23B
Q1 2021Q2 2026
13F filings of Clough Capital Partners L P by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 2026101$1.23BGOOGAMZNNVDAvs. Q1 2026SEC
Q1 2026May 15, 202695$1.04BGOOGNVDAAMZNvs. Q4 2025SEC
Q4 2025Feb 17, 2026106$1.11BAMZNGOOGCCLvs. Q3 2025SEC
Q3 2025Nov 14, 2025106$1.12BAMZNMETAGOOGvs. Q2 2025SEC
Q2 2025Aug 14, 2025116$997.2MCCLAMZNMSFTvs. Q1 2025SEC
Q1 2025May 15, 2025104$792.4MMSFTMETAPMvs. Q4 2024SEC
Q4 2024Feb 14, 2025118$873.7MAMZNGOOGEXEvs. Q3 2024SEC
Q3 2024Nov 14, 2024132$977.0MGOOGAAPLMSFTvs. Q2 2024SEC
Q2 2024Aug 14, 2024118$915.8MMSFTAAPLGOOGvs. Q1 2024SEC
Q1 2024May 15, 2024117$909.6MMSFTGOOGAMZNvs. Q4 2023SEC
Q4 2023Feb 14, 2024192$904.1MMSFTGOOGBAvs. Q3 2023SEC
Q3 2023Nov 14, 2023202$931.9MGOOGMSFTGDvs. Q2 2023SEC
Q2 2023Aug 14, 2023176$993.8MGOOGMSFTRTXvs. Q1 2023SEC
Q1 2023May 15, 2023164$927.8MNOCRTXBAvs. Q4 2022SEC
Q4 2022Feb 14, 2023158$986.5MRTXNOCHDBvs. Q3 2022SEC
Q3 2022Nov 14, 202280$669.7MMSFTRTXAAPLvs. Q2 2022SEC
Q2 2022Aug 16, 202276$773.0MRTXSTWDVvs. Q1 2022SEC
Q1 2022May 16, 2022113$1.31BMSFTSTWDAMZNvs. Q4 2021SEC
Q4 2021Feb 14, 2022110$1.49BAMZNMUPFSIvs. Q3 2021SEC
Q3 2021Nov 15, 2021110$1.61BMSFTAMZNFAFvs. Q2 2021SEC
Q2 2021Aug 16, 2021130$1.78BAMZNPFSIFAFvs. Q1 2021SEC
Q1 2021May 17, 2021132$1.54BPFSINLYFAF–SEC

13D and 13G filings

Companies where Clough Capital Partners L P reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Clough Capital Partners L P does not currently report owning 5% or more of any company.

Latest filings

3 filings on file made by Clough Capital Partners L P or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Clough Capital Partners L P
CompanyFiled (ET)FormStakeChangeEvent dateFiling
CMPICheckmate Pharmaceuticals, Inc.Feb 14, 202213G/AOld format–––SEC
CMPICheckmate Pharmaceuticals, Inc.May 24, 202113G/AOld format–––SEC
CMPICheckmate Pharmaceuticals, Inc.Feb 12, 202113G/AOld format–––SEC